Figure 3 U‑shape relationship between exercise dose and risk of atrial fibrillation (AF) Figure 3 | U-shape relationship between exercise dose and risk.

Slides:



Advertisements
Similar presentations
Endurance sport practice as a risk factor for atrial fibrillation and atrial flutter by Lluís Mont, Roberto Elosua, and Josep Brugada Europace Volume 11(1):11-17.
Advertisements

Date of download: 6/23/2016 Copyright © The American College of Cardiology. All rights reserved. From: Impact of CARDIOrespiratory FITness on Arrhythmia.
Figure 1 Initial management of a patient with acute heart failure
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Overall burden of AF associated with higher risk of thromboembolism and ischemic stroke An analysis of the KP-RHYTHM study, in patients with paroxysmal.
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Figure 5 BMI and cardiorespiratory fitness levels
Nat. Rev. Cardiol. doi: /nrcardio
Figure 4 Pharmacodynamic comparison of crushed versus integral
Figure 4 BMI and mortality in patients with heart failure
Risk factors for atrial fibrillation
Figure 2 Pathological specimens showing the most common reasons for bioprosthetic valve failure Figure 2 | Pathological specimens showing the most common.
Nat. Rev. Cardiol. doi: /nrcardio
Figure 3 Global rates of sodium, fruit, and vegetable intake
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Figure 2 Three-year survival rates on the basis of body composition
Figure 7 European Society of Cardiology 2016
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Figure 6 Pharmacodynamic profile of switching between clopidogrel and ticagrelor therapy: results from the RESPOND study Figure 6| Pharmacodynamic profile.
Nat. Rev. Cardiol. doi: /nrcardio
Figure 4 Prevalence of HFpEF and HFrEF by age
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Figure 5 Proposed clinical approach in athletes
Nat. Rev. Cardiol. doi: /nrcardio
Figure 1 Health-care system today
Figure 2 Determination of phase values
Figure 1 Cardiovascular risk and disease across the life-course
Nat. Rev. Cardiol. doi: /nrcardio
Figure 2 The depolarization theory of Brugada syndrome
Figure 6 Proposed arrhythmogenic right ventricular
Figure 1 Decision tree integrating the assessment,
Figure 3 Neural crest cell migration
Figure 2 Global cost of HF per capita in 2012
Nat. Rev. Cardiol. doi: /nrcardio
Figure 3 Challenges for big data applications in cardiovascular care
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Figure 2 Absolute difference in seasonal peak
Nat. Rev. Cardiol. doi: /nrcardio
Figure 5 Bioresorbable vascular scaffold apposition and strut coverage
Figure 6 Combining population-wide and high-risk strategies
Figure 6 The neurogenic components of angina
Figure 1 Rates of complications and mortality during index admission for atrial fibrillation ablation for the overall ... Figure 1 Rates of complications.
Figure 9 Management of atrial fibrillation
Nat. Rev. Cardiol. doi: /nrcardio
Figure 2 Impaired mitochondrial capacity and function in heart failure
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
(A) Kaplan-Meier curve showing AF-free survival after a single procedure for patients grouped according to use of CT integration. (A) Kaplan-Meier curve.
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Overall burden of AF associated with higher risk of thromboembolism and ischemic stroke An analysis of the KP-RHYTHM study, in patients with paroxysmal.
Nat. Rev. Cardiol. doi: /nrcardio
Figure 1 Novel markers of increased stroke risk in AF
Nat. Rev. Cardiol. doi: /nrcardio
Presentation transcript:

Figure 3 U‑shape relationship between exercise dose and risk of atrial fibrillation (AF) Figure 3 | U-shape relationship between exercise dose and risk of atrial fibrillation (AF). a | Proposed overall curve. b | Clinical evidence for a U-shape relationship between exercise duration of vigorous physical activity (in hours) and risk of AF15. c,d | Clinical evidence for a U-shape relationship between intensity of physical activity and risk of AF. CRF MET, cardiorespiratory fitness, metabolic equivalent. Panel b is reprinted from Calvo, N. et al. Emerging risk factors and the dose-response relationship between physical activity and lone atrial fibrillation: a prospective case-control study. Europace 18, 57–63 (2016), with permission from Oxford University Press. Panel c is reprinted from Khan, H. et al. Cardiorespiratory fitness and atrial fibrillation: a population-based follow-up study. Heart Rhythm 12, 1424–1430 (2015), with permission from Elsevier. Panel d is reprinted from Morseth, B. et al. Physical activity, resting heart rate, and atrial fibrillation: the Tromsø Study. Eur. Heart J. 37, 2307–2313 (2016), with permission from Oxford University Press. Panel b is reprinted from Calvo, N. et al. Emerging risk factors and the dose-response relationship between physical activity and lone atrial fibrillation: a prospective case-control study. Europace 18, 57–63 (2016), with permission from Oxford University Press. Panel c is reprinted from Khan, H. et al. Cardiorespiratory fitness and atrial fibrillation: a population-based follow-up study. Heart Rhythm 12, 1424–1430 (2015), with permission from Elsevier. Panel d is reprinted from Morseth, B. et al. Physical activity, resting heart rate, and atrial fibrillation: the Tromsø Study. Eur. Heart J. 37, 2307–2313 (2016), with permission from Oxford University Press Guasch, E. & Mont, L. (2016) Diagnosis, pathophysiology, and management of exercise-induced arrhythmias Nat. Rev. Cardiol. doi:10.1038/nrcardio.2016.173